Skip to content

FP7

NANOMAL

Development of a handheld antimalarial drug resistance diagnostic device using nanowire technology

Programme
Seventh Framework Programme
Started
Ends
Duration
36 months
Total cost
EUR 5,236,311
EU contribution
EUR 3,992,150
Participants
4 from 3 countries
Topic
FP7_HEALTH.2012.2.3.0-1
Grant agreement
304948

Coordinated by St George's Hospital Medical School (GBUnited Kingdom).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium
OrganisationCountryRoleEU contributionRecognised by
St George's Hospital Medical SchoolGBUnited KingdomCoordinatorEUR 994,655PIC (1.00)
Eberhard Karls Universitaet TuebingenDEGermanyParticipantEUR 172,200PIC (1.00)
Quantumdx Group LimitedGBUnited KingdomParticipantEUR 2,629,416PIC (1.00)
Karolinska InstitutetSESwedenParticipantEUR 195,879known name (0.95)

Changes of the consortium

First seen on with 4 participants from 3 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.